KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Share-based Compensation: 2009-2025

Historic Share-based Compensation for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $23.3 million.

  • Charles River Laboratories International's Share-based Compensation rose 20.36% to $23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.7 million, marking a year-over-year decrease of 2.07%. This contributed to the annual value of $69.9 million for FY2024, which is 2.99% down from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Share-based Compensation is $23.3 million, which was up 36.47% from $17.0 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Share-based Compensation ranged from a high of $23.3 million in Q3 2025 and a low of $13.1 million during Q1 2025.
  • For the 3-year period, Charles River Laboratories International's Share-based Compensation averaged around $17.8 million, with its median value being $17.0 million (2025).
  • Per our database at Business Quant, Charles River Laboratories International's Share-based Compensation skyrocketed by 30.55% in 2021 and then fell by 21.53% in 2025.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Share-based Compensation stood at $19.2 million in 2021, then climbed by 15.03% to $22.1 million in 2022, then declined by 11.55% to $19.5 million in 2023, then declined by 11.71% to $17.2 million in 2024, then grew by 20.36% to $23.3 million in 2025.
  • Its Share-based Compensation stands at $23.3 million for Q3 2025, versus $17.0 million for Q2 2025 and $13.1 million for Q1 2025.